Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 2/20 | 0.44 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.44 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.44 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.44 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.44 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 4/20 | 0.43 |
| ▸ | TBXAS1 | P24557 | 9/20 | 0.41 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9092744 | 0.80 | SIGMAR1 (0.53) | MTNR1AMTNR1BCHRNB2CHRNB4CHRNA3 | |
| SCHEMBL1226475 | 0.76 | MTNR1A (0.52) | MTNR1AMTNR1BCHRNB2CHRNB4CHRNA3 | |
| SCHEMBL7750965 | 0.75 | MTNR1A (0.40) | MTNR1AMTNR1BCHRNB2CHRNB4CHRNA3 | |
| SCHEMBL9717829 | 0.74 | TBXAS1 (0.53) | MTNR1AMTNR1BCHRNB2CHRNB4CHRNA3 | |
| SCHEMBL4630812 | 0.73 | MTNR1A (0.48) | MTNR1AMTNR1BCHRNB2CHRNB4CHRNA3 | |
| SCHEMBL1226216 | 0.73 | SIGMAR1 (0.49) | MTNR1AMTNR1BCHRNB2CHRNB4CHRNA3 | |
| SCHEMBL11680510 | 0.73 | SIGMAR1 (0.47) | MTNR1AMTNR1BCHRNB2CHRNB4CHRNA3 | |
| SCHEMBL7736497 | 0.73 | SIGMAR1 (0.47) | MTNR1AMTNR1BCHRNB2CHRNB4CHRNA3 | |
| SCHEMBL5636415 | 0.73 | SIGMAR1 (0.47) | MTNR1AMTNR1BCHRNB2CHRNB4CHRNA3 | |
| SCHEMBL4535241 | 0.73 | SIGMAR1 (0.47) | MTNR1AMTNR1BCHRNB2CHRNB4CHRNA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 911 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240010836-A1 | POLYAMIDE PARTS WITH LOW FUEL PERMEATION | EMS-CHEMIE AG (CH) | 2024-01-11 | — | — | US | claimed |
| EP-4303259-A1 | POLYAMIDE PARTS WITH LOW FUEL PERMEATION | EMS-CHEMIE AG (CH) | 2024-01-10 | — | — | EP | claimed |
| US-11692085-B2 | Geomembranes and methods for making and using the same | UNIVERSITY OF SOUTH FLORIDA (US) | 2023-07-04 | — | — | US | claimed |
| EP-2864310-B1 | STABILIZER COMPOSITIONS CONTAINING SUBSTITUTED CHROMAN COMPOUNDS AND METHODS OF USE | CYTEC TECH CORP (US) | 2022-10-26 | — | — | EP | claimed |
| US-20210292526-A1 | GEOMEMBRANES AND METHODS FOR MAKING AND USING THE SAME | UNIVERSITY OF SOUTH FLORIDA | 2021-09-23 | — | — | US | claimed |
| US-10913743-B2 | Use of organic oxyimides as flame retardant for plastic materials and also flame-retardant plastic material composition and moulded parts produced therefrom | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) | 2021-02-09 | — | — | US | claimed |
| US-10882975-B2 | Flameproof, aliphatic polyketone materials, moulded articles produced therefrom and also method for the production thereof | EMS-PATENT AG (CH) | 2021-01-05 | — | — | US | claimed |
| EP-2652014-B1 | PROCESSING ADDITIVES AND USES OF SAME IN ROTATIONAL MOLDING | CYTEC TECH CORP (US) | 2020-07-01 | — | — | EP | claimed |
| EP-3558469-B1 | MALODOR REDUCTION OF COSMETIC COMPOSITIONS | UNILEVER PLC (GB) | 2020-05-20 | — | — | EP | claimed |
| CN-111051322-A | Stabilized polyolefin compositions comprising benzofuranones and organophosphorus stabilizers | 巴斯夫欧洲公司 | 2020-04-21 | — | — | CN | claimed |
| EP-2748227-B1 | POLYSULFONE COMPOSITIONS AND METHODS FOR THE MANUFACTURE AND USE THEREOF | SABIC GLOBAL TECHNOLOGIES BV (NL) | 2017-11-01 | — | — | EP | claimed |
| US-20170137608-A1 | FLAMEPROOF, ALIPHATIC POLYKETONE MATERIALS, MOULDED ARTICLES PRODUCED THEREFROM AND ALSO METHOD FOR THE PRODUCTION THEREOF | EMS-PATENT AG (CH) | 2017-05-18 | — | — | US | claimed |
| US-20170137609-A1 | POLYKETONE MOULDING COMPOUNDS WITH IMPROVED PROPERTIES, MOULDED ARTICLES PRODUCED THEREFROM AND ALSO METHOD FOR THE PRODUCTION THEREOF | EMS-PATENT AG (CH) | 2017-05-18 | — | — | US | claimed |
| US-20150218374-A1 | POLYAMIDE MOULDING COMPOUNDS WITH FLAME-RETARDANT PROPERTIES AND VERY GOOD LONG-TERM HEAT-AGEING RESISTANCE | EMS-PATENT AG (CH) | 2015-08-06 | — | — | US | claimed |
| WO-2012113520-A1 | FLAME RETARDANT-STABILISER COMBINATION FOR THERMOPLASTIC POLYMERS | CLARIANT INTERNATIONAL LTD (CH) | 2012-08-30 | — | — | WO | claimed |
| EP-0905180-B1 | Dust free stabiliser granules containing epoxide and process of their preparation | CIBA SC HOLDING AG (CH) | 2003-05-21 | — | — | EP | claimed |
| EP-0905180-A2 | Dust free stabiliser granules containing epoxide and process of their preparation | Ciba SC Holding AG (CH) | 1999-03-31 | — | — | EP | claimed |
| EP-0142467-B1 | POLYMER COMPOUNDS CONTAINING PIPERIDYL GROUPS AND THEIR USE AS STABILISERS IN SYNTHETIC POLYMERS | CIBA-GEIGY S.p.A. (IT) | 1988-08-24 | — | — | EP | claimed |
| EP-0140297-A2 | Thiocarbamic-acid esters as stabilizers | CIBA-GEIGY AG (CH) | 1985-05-08 | — | — | EP | claimed |
| EP-0108714-A1 | Dibenzodioxaphosphepine and dioxaphosphocine processing stabilizers | CIBA-GEIGY AG (CH) | 1984-05-16 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10913743-B2 | Use of organic oxyimides as flame retardant for plastic materials and also flame-retardant plastic material composition and moulded parts produced therefrom | ORMDL3, OGDH, FTO | MTNR1A 3174/4885MTNR1B 3354/4885CHRNB2 3721/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.